← Leaderboards
Dan Theodorescu
Methodist Hospital Research Institute
$43,145,134
Attributed
$49,734,641
Total exposure
47
Grants
35
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.8M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$108,089,212 · 51
By mechanism
P30$55,368,474 · 24
P01$23,416,111 · 9
R01$15,590,138 · 5
U54$11,111,372 · 8
P50$1,392,398 · 2
R35$930,500 · 1
Top collaborators
- Keith Syson Chan11 shared
- Bryce M Paschal11 shared
- James Christopher Costello5 shared
- David Ross5 shared
- Martin A. Schwartz5 shared
- Anindya Dutta3 shared
- Henry F Frierson3 shared
- David Wotton3 shared
Others in their field
Top investigators on “Programs”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,641,009,751
- Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
- Lawrence Corey · Fred Hutchinson Cancer Center$730,186,538
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$609,313,548
Research focus
ProgramsMalignant NeoplasmsMemberFundingUniversitiesColoradoCancer Center Support GrantFutureResearch PersonnelTumorBasePeer ReviewPublicationsResourcesResource SharingGrantClinical TrialsAnticancer ResearchAreaInstitutionCancer CellDesignLeadershipCollaborations
Grant awards (200)
University of Arizona Cancer Center - Cancer Center Support Grant$4,026,608
P30 · FY2025 · CA · contact PI
The stromal microenvironment as a co-organizer of bladder carcinogenesis and progression$1,646,006
U54 · FY2025 · CA
Understanding and Exploiting Loss of Y in Cancer$930,500
R35 · FY2025 · CA · contact PI
The Role of the Y Chromosome in Bladder Tumor Development, Growth And Progression$543,058
P01 · FY2025 · CA · contact PI
Project 2$339,948
U54 · FY2025 · CA · contact PI
The stromal microenvironment as a co-organizer of bladder carcinogenesis and progression$1,564,827
U54 · FY2024 · CA
Targeting the mutant promoter of Telomerase Reverse Transcriptase (TERT)$563,904
R01 · FY2024 · CA · contact PI
The Role of the Y Chromosome in Bladder Tumor Development, Growth And Progression$515,907
P01 · FY2024 · CA · contact PI
NPEPPS is a novel and druggable determinant of chemotherapy resistance in bladder cancer$476,566
R01 · FY2024 · CA · contact PI
Discoidin Domain Receptor Tyrosine Kinase 2 in bladder cancer progression$392,659
R01 · FY2024 · CA · contact PI
Project 2$323,195
U54 · FY2024 · CA · contact PI
A single-cell spatial map characterizing the stromal TME in bladder and breast early-lesions$174,625
U54 · FY2024 · CA
NPEPPS is a novel and druggable determinant of chemotherapy resistance in bladder cancer$80,996
R01 · FY2024 · CA · contact PI
Investigating NPEPPS-mediated feedback between bladder cancer cells and peripheral neurons as a mechanism of cisplatin resistance$9,180
R01 · FY2024 · CA · contact PI
The stromal microenvironment as a co-organizer of bladder carcinogenesis and progression$1,657,891
U54 · FY2023 · CA
Project-004$822,274
U54 · FY2023 · CA
Targeting the mutant promoter of Telomerase Reverse Transcriptase (TERT)$772,180
R01 · FY2023 · CA · contact PI
Project-006$765,000
U54 · FY2023 · CA
Project-005$636,346
U54 · FY2023 · CA
Core-002$562,163
U54 · FY2023 · CA
The Role of the Y Chromosome in Bladder Tumor Development, Growth And Progression$543,058
P01 · FY2023 · CA · contact PI
NPEPPS is a novel and druggable determinant of chemotherapy resistance in bladder cancer$491,617
R01 · FY2023 · CA · contact PI
Discoidin Domain Receptor Tyrosine Kinase 2 in bladder cancer progression$413,325
R01 · FY2023 · CA · contact PI
Admin-Core-002$344,319
U54 · FY2023 · CA
Spatial and mechanistic assessment of the role of stromal fibroblasts in driving emergence of aggressive prostate and bladder cancer$83,500
U54 · FY2023 · CA
The stromal microenvironment as a co-organizer of bladder carcinogenesis and progression$1,745,043
U54 · FY2022 · CA
NPEPPS is a novel and druggable determinant of chemotherapy resistance in bladder cancer$518,399
R01 · FY2022 · CA · contact PI
Project 2$446,235
U54 · FY2022 · CA · contact PI
Discoidin Domain Receptor Tyrosine Kinase 2 in bladder cancer progression$405,059
R01 · FY2022 · CA · contact PI
Administrative Core$505,878
P30 · FY2021 · CA · contact PI
Clinical Protocol & Data Management$439,957
P30 · FY2021 · CA · contact PI
Discoidin Domain Receptor Tyrosine Kinase 2 in bladder cancer progression$413,325
R01 · FY2021 · CA · contact PI
Molecular Pathology Shared Resource$315,958
P30 · FY2021 · CA · contact PI
Flow Cytometry Shared Resource$291,101
P30 · FY2021 · CA · contact PI
Biostatistics / Bioinformatics Shared Resource$280,729
P30 · FY2021 · CA · contact PI
Protein Production / Monoclonal Antibody / Tissue Culture Shared Resource$218,900
P30 · FY2021 · CA · contact PI
Functional Genomics Shared Resource$185,637
P30 · FY2021 · CA · contact PI
Tissue Biobanking & Processing Shared Resource$180,516
P30 · FY2021 · CA · contact PI
Animal Imaging Shared Resource$175,300
P30 · FY2021 · CA · contact PI
Structural Biology Shared Resource$161,760
P30 · FY2021 · CA · contact PI
Genomics Shared Resource$159,142
P30 · FY2021 · CA · contact PI
Protocol Review & Monitoring System$136,664
P30 · FY2021 · CA · contact PI
Early Phase Clinical Research Support$128,514
P30 · FY2021 · CA · contact PI
Pharmacology Shared Resource$119,227
P30 · FY2021 · CA · contact PI
Developmental Funds$90,232
P30 · FY2021 · CA · contact PI
Hematologic Malignancies Program$71,335
P30 · FY2021 · CA · contact PI
Lung, Head & Neck Cancers Program$71,335
P30 · FY2021 · CA · contact PI
Molecular Oncology Program$71,335
P30 · FY2021 · CA · contact PI
Cancer Prevention and Control Program$71,335
P30 · FY2021 · CA · contact PI
Developmental Therapeutics Program$70,379
P30 · FY2021 · CA · contact PI
Cancer Cell Biology Program$68,807
P30 · FY2021 · CA · contact PI
Planning and Evaluation$39,185
P30 · FY2021 · CA · contact PI
Administrative Core$505,878
P30 · FY2020 · CA · contact PI
Understanding the AGL metastasis suppressor for therapeutic gain$482,883
R01 · FY2020 · CA · contact PI
Clinical Protocol & Data Management$439,957
P30 · FY2020 · CA · contact PI
Molecular Pathology Shared Resource$315,958
P30 · FY2020 · CA · contact PI
Flow Cytometry Shared Resource$291,101
P30 · FY2020 · CA · contact PI
Biostatistics / Bioinformatics Shared Resource$280,729
P30 · FY2020 · CA · contact PI
Protein Production / Monoclonal Antibody / Tissue Culture Shared Resource$218,900
P30 · FY2020 · CA · contact PI
Functional Genomics Shared Resource$185,637
P30 · FY2020 · CA · contact PI
Tissue Biobanking & Processing Shared Resource$180,516
P30 · FY2020 · CA · contact PI
Animal Imaging Shared Resource$175,300
P30 · FY2020 · CA · contact PI
Structural Biology Shared Resource$161,760
P30 · FY2020 · CA · contact PI
Genomics Shared Resource$159,142
P30 · FY2020 · CA · contact PI
Pharmacology Shared Resource$155,500
P30 · FY2020 · CA · contact PI
Protocol Review & Monitoring System$136,664
P30 · FY2020 · CA · contact PI
Early Phase Clinical Research Support$128,514
P30 · FY2020 · CA · contact PI
Pharmacology Shared Resource$119,227
P30 · FY2020 · CA · contact PI
Developmental Funds$90,232
P30 · FY2020 · CA · contact PI
Hematologic Malignancies Program$71,335
P30 · FY2020 · CA · contact PI
Cancer Prevention and Control Program$71,335
P30 · FY2020 · CA · contact PI
Lung, Head & Neck Cancers Program$71,335
P30 · FY2020 · CA · contact PI
Molecular Oncology Program$71,335
P30 · FY2020 · CA · contact PI
Developmental Therapeutics Program$70,379
P30 · FY2020 · CA · contact PI
Cancer Cell Biology Program$68,807
P30 · FY2020 · CA · contact PI
Planning and Evaluation$39,185
P30 · FY2020 · CA · contact PI
Administrative Core$505,878
P30 · FY2019 · CA · contact PI
Understanding the AGL metastasis suppressor for therapeutic gain$474,242
R01 · FY2019 · CA · contact PI
Clinical Protocol & Data Management$439,957
P30 · FY2019 · CA · contact PI
Regulation and Targeting of CD24 in Bladder Cancer$391,637
R01 · FY2019 · CA · contact PI
Molecular Pathology Shared Resource$315,958
P30 · FY2019 · CA · contact PI
Flow Cytometry Shared Resource$291,101
P30 · FY2019 · CA · contact PI
Biostatistics / Bioinformatics Shared Resource$280,729
P30 · FY2019 · CA · contact PI
Protein Production / Monoclonal Antibody / Tissue Culture Shared Resource$218,900
P30 · FY2019 · CA · contact PI
Functional Genomics Shared Resource$185,637
P30 · FY2019 · CA · contact PI
Tissue Biobanking & Processing Shared Resource$180,516
P30 · FY2019 · CA · contact PI
Animal Imaging Shared Resource$175,300
P30 · FY2019 · CA · contact PI
Structural Biology Shared Resource$161,760
P30 · FY2019 · CA · contact PI
Genomics Shared Resource$159,142
P30 · FY2019 · CA · contact PI
Protocol Review & Monitoring System$136,664
P30 · FY2019 · CA · contact PI
Early Phase Clinical Research Support$128,514
P30 · FY2019 · CA · contact PI
Pharmacology Shared Resource$119,227
P30 · FY2019 · CA · contact PI
Developmental Funds$90,232
P30 · FY2019 · CA · contact PI
Cancer Prevention and Control Program$71,335
P30 · FY2019 · CA · contact PI
Lung, Head & Neck Cancers Program$71,335
P30 · FY2019 · CA · contact PI
Molecular Oncology Program$71,335
P30 · FY2019 · CA · contact PI
Hematologic Malignancies Program$71,335
P30 · FY2019 · CA · contact PI
Developmental Therapeutics Program$70,379
P30 · FY2019 · CA · contact PI
Cancer Cell Biology Program$68,807
P30 · FY2019 · CA · contact PI
Planning and Evaluation$39,185
P30 · FY2019 · CA · contact PI
Understanding the AGL metastasis suppressor for therapeutic gain$481,438
R01 · FY2018 · CA · contact PI
Administrative Core$385,983
P30 · FY2018 · CA · contact PI
Regulation and Targeting of CD24 in Bladder Cancer$357,944
R01 · FY2018 · CA · contact PI
Clinical Protocol & Data Management$343,589
P30 · FY2018 · CA · contact PI
Molecular Pathology Shared Resource$263,847
P30 · FY2018 · CA · contact PI
Flow Cytometry Shared Resource$247,861
P30 · FY2018 · CA · contact PI
Biostatistics / Bioinformatics Shared Resource$241,190
P30 · FY2018 · CA · contact PI
Pharmacology Shared Resource$223,326
P30 · FY2018 · CA · contact PI
Protein Production / Monoclonal Antibody / Tissue Culture Shared Resource$201,430
P30 · FY2018 · CA · contact PI
Functional Genomics Shared Resource$180,039
P30 · FY2018 · CA · contact PI
Tissue Biobanking & Processing Shared Resource$176,746
P30 · FY2018 · CA · contact PI
Animal Imaging Shared Resource$173,391
P30 · FY2018 · CA · contact PI
Pharmacology Shared Resource$170,455
P30 · FY2018 · CA · contact PI
Structural Biology Shared Resource$164,684
P30 · FY2018 · CA · contact PI
Genomics Shared Resource$163,000
P30 · FY2018 · CA · contact PI
Understanding the AGL metastasis suppressor for therapeutic gain$149,644
R01 · FY2018 · CA · contact PI
Protocol Review & Monitoring System$148,544
P30 · FY2018 · CA · contact PI
Early Phase Clinical Research Support$143,303
P30 · FY2018 · CA · contact PI
Developmental Funds$118,685
P30 · FY2018 · CA · contact PI
Developmental Therapeutics Program$113,590
P30 · FY2018 · CA · contact PI
Molecular Oncology Program$106,532
P30 · FY2018 · CA · contact PI
Hematologic Malignancies Program$106,531
P30 · FY2018 · CA · contact PI
Lung, Head & Neck Cancers Program$106,531
P30 · FY2018 · CA · contact PI
Cancer Prevention and Control Program$106,531
P30 · FY2018 · CA · contact PI
Cancer Cell Biology Program$104,905
P30 · FY2018 · CA · contact PI
Planning and Evaluation$85,859
P30 · FY2018 · CA · contact PI
Regulation and Targeting of CD24 in Bladder Cancer$41,899
R01 · FY2018 · CA · contact PI
University of Colorado Cancer Center Support Grant$39,685
P30 · FY2018 · CA · contact PI
Planning and Evaluation$11,071
P30 · FY2018 · CA · contact PI
Biostatistics / Bioinformatics Shared Resource$11,071
P30 · FY2018 · CA · contact PI
Developmental Funds$11,071
P30 · FY2018 · CA · contact PI
Animal Imaging Shared Resource$11,071
P30 · FY2018 · CA · contact PI
Genomics Shared Resource$11,071
P30 · FY2018 · CA · contact PI
Functional Genomics Shared Resource$11,071
P30 · FY2018 · CA · contact PI
Administrative Core$11,071
P30 · FY2018 · CA · contact PI
Flow Cytometry Shared Resource$11,071
P30 · FY2018 · CA · contact PI
Cancer Cell Biology Program$11,070
P30 · FY2018 · CA · contact PI
Hematologic Malignancies Program$11,070
P30 · FY2018 · CA · contact PI
Lung, Head & Neck Cancers Program$11,070
P30 · FY2018 · CA · contact PI
Early Phase Clinical Research Support$11,070
P30 · FY2018 · CA · contact PI
Molecular Pathology Shared Resource$11,070
P30 · FY2018 · CA · contact PI
Pharmacology Shared Resource$11,070
P30 · FY2018 · CA · contact PI
Protein Production / Monoclonal Antibody / Tissue Culture Shared Resource$11,070
P30 · FY2018 · CA · contact PI
Structural Biology Shared Resource$11,070
P30 · FY2018 · CA · contact PI
Tissue Biobanking & Processing Shared Resource$11,070
P30 · FY2018 · CA · contact PI
Clinical Protocol & Data Management$11,070
P30 · FY2018 · CA · contact PI
Cancer Prevention and Control Program$11,070
P30 · FY2018 · CA · contact PI
Protocol Review & Monitoring System$11,070
P30 · FY2018 · CA · contact PI
Developmental Therapeutics Program$11,070
P30 · FY2018 · CA · contact PI
Molecular Oncology Program$11,069
P30 · FY2018 · CA · contact PI
Biostatistics / Bioinformatics Shared Resource$1,805
P30 · FY2018 · CA · contact PI
Animal Imaging Shared Resource$1,805
P30 · FY2018 · CA · contact PI
Developmental Funds$1,805
P30 · FY2018 · CA · contact PI
Planning and Evaluation$1,805
P30 · FY2018 · CA · contact PI
Administrative Core$1,805
P30 · FY2018 · CA · contact PI
Functional Genomics Shared Resource$1,804
P30 · FY2018 · CA · contact PI
Molecular Pathology Shared Resource$1,804
P30 · FY2018 · CA · contact PI
Structural Biology Shared Resource$1,804
P30 · FY2018 · CA · contact PI
Flow Cytometry Shared Resource$1,804
P30 · FY2018 · CA · contact PI
Genomics Shared Resource$1,804
P30 · FY2018 · CA · contact PI
Pharmacology Shared Resource$1,804
P30 · FY2018 · CA · contact PI
Clinical Protocol & Data Management$1,804
P30 · FY2018 · CA · contact PI
Protein Production / Monoclonal Antibody / Tissue Culture Shared Resource$1,804
P30 · FY2018 · CA · contact PI
Tissue Biobanking & Processing Shared Resource$1,804
P30 · FY2018 · CA · contact PI
Molecular Oncology Program$1,803
P30 · FY2018 · CA · contact PI
Protocol Review & Monitoring System$1,803
P30 · FY2018 · CA · contact PI
Early Phase Clinical Research Support$1,803
P30 · FY2018 · CA · contact PI
Cancer Cell Biology Program$1,803
P30 · FY2018 · CA · contact PI
Cancer Prevention and Control Program$1,803
P30 · FY2018 · CA · contact PI
Developmental Therapeutics Program$1,803
P30 · FY2018 · CA · contact PI
Hematologic Malignancies Program$1,803
P30 · FY2018 · CA · contact PI
Lung, Head & Neck Cancers Program$1,803
P30 · FY2018 · CA · contact PI
University of Colorado Cancer Center Support Grant$3,880,607
P30 · FY2017 · CA · contact PI
Administrative Core$562,860
P30 · FY2017 · CA · contact PI
Clinical Protocol & Data Management$485,070
P30 · FY2017 · CA · contact PI
Understanding the AGL metastasis suppressor for therapeutic gain$435,425
R01 · FY2017 · CA · contact PI
Regulation and Targeting of CD24 in Bladder Cancer$369,313
R01 · FY2017 · CA · contact PI
Molecular Pathology Shared Resource$341,237
P30 · FY2017 · CA · contact PI
Flow Cytometry Shared Resource$312,833
P30 · FY2017 · CA · contact PI
Biostatistics / Bioinformatics Shared Resource$298,294
P30 · FY2017 · CA · contact PI
Protein Production / Monoclonal Antibody / Tissue Culture Shared Resource$228,428
P30 · FY2017 · CA · contact PI
Functional Genomics Shared Resource$186,754
P30 · FY2017 · CA · contact PI
Tissue Biobanking & Processing Shared Resource$181,130
P30 · FY2017 · CA · contact PI
Animal Imaging Shared Resource$175,827
P30 · FY2017 · CA · contact PI
Structural Biology Shared Resource$159,366
P30 · FY2017 · CA · contact PI
Genomics Shared Resource$157,563
P30 · FY2017 · CA · contact PI
Understanding the AGL metastasis suppressor for therapeutic gain$136,880
R01 · FY2017 · CA · contact PI
Protocol Review & Monitoring System$129,312
P30 · FY2017 · CA · contact PI
Pharmacology Shared Resource$123,080
P30 · FY2017 · CA · contact PI
Early Phase Clinical Research Support$119,751
P30 · FY2017 · CA · contact PI
University of Colorado Cancer Center Support Grant$104,106
P30 · FY2017 · CA · contact PI
Developmental Funds$77,750
P30 · FY2017 · CA · contact PI
Developmental Therapeutics Program$65,366
P30 · FY2017 · CA · contact PI
Lung, Head & Neck Cancers Program$52,680
P30 · FY2017 · CA · contact PI
Molecular Oncology Program$52,680
P30 · FY2017 · CA · contact PI
Hematologic Malignancies Program$52,680
P30 · FY2017 · CA · contact PI
Cancer Prevention and Control Program$52,680
P30 · FY2017 · CA · contact PI
Cancer Cell Biology Program$49,716
P30 · FY2017 · CA · contact PI
Planning and Evaluation$15,550
P30 · FY2017 · CA · contact PI
University of Colorado Cancer Center Support Grant$3,780
P30 · FY2017 · CA · contact PI